Reuters logo
a month ago
BRIEF-Trovagene enters into agreement with Astrazeneca to utilize Trovera CTDNA test and services in prospective biomarker study
June 12, 2017 / 12:15 PM / a month ago

BRIEF-Trovagene enters into agreement with Astrazeneca to utilize Trovera CTDNA test and services in prospective biomarker study

1 Min Read

June 12 (Reuters) - Trovagene Inc

* Trovagene enters into agreement with astrazeneca to utilize trovera® ctdna test and services in prospective biomarker study

* Trovagene Inc - has entered into an agreement with astrazeneca to provide trovera® urine ctdna biomarker test and services

* Trovagene Inc - trovera egfr urine liquid biopsy test will initially be used in an open label prospective biomarker study Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below